Literature DB >> 6108737

Minoxidil.

S L Linas, A S Nies.   

Abstract

Minoxidil is an orally active vasodilator for treatment of severe hypertension. In combination with diuretics and beta-adrenergic blocking agents, it is effective treatment for more than 80% of patients whose blood pressure has been inadequately controlled with combinations of other been inadequately controlled with combinations of other antihypertensive drugs. Major adverse reactions include reflex activation of the adrenergic nervous system, renal sodium retention, and hypertrichosis. Despite the possibility of adverse reactions, minoxidil is indicated in patients whose blood pressure cannot be controlled with conventional therapy, in persons with major adverse reactions to other drugs, and in patients who are candidates for bilateral nephrectomy for control of hypertension.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6108737     DOI: 10.7326/0003-4819-94-1-61

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  12 in total

1.  Pharmacokinetics and hemodynamic and diuretic/natriuretic effects of felodipine administered as an extended-release tablet.

Authors:  B Hasselgren; O Rönn; B Edgar; P Johansson; B Wall
Journal:  Cardiovasc Drugs Ther       Date:  1990-12       Impact factor: 3.727

2.  Mechanism of activation of K+ channels by minoxidil-sulfate in Madin-Darby canine kidney cells.

Authors:  A Schwab; J Geibel; W Wang; H Oberleithner; G Giebisch
Journal:  J Membr Biol       Date:  1993-03       Impact factor: 1.843

3.  Could Topical Minoxidil Cause Non-Arteritic Anterior Ischemic Optic Neuropathy?

Authors:  Habibullah Aktas; Sevil Alan; Elif Betül Türkoglu; Özge Sevik
Journal:  J Clin Diagn Res       Date:  2016-08-01

4.  Natriuretic and diuretic effects of felodipine and hydrochlorothiazide after single and repeated doses.

Authors:  B Hasselgren; P Johansson
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

5.  Influence of minoxidil on myocardial hemodynamics, regional blood flow, and morphology in beagle dogs.

Authors:  G K Jett; E H Herman; M Jones; V J Ferrans; R E Clark
Journal:  Cardiovasc Drugs Ther       Date:  1988-03       Impact factor: 3.727

6.  Acute diuretic/natriuretic properties of felodipine in man.

Authors:  B Edgar; B Bengtsson; D Elmfeldt; P Lundborg; G Nyberg; S Raner; O Rönn
Journal:  Drugs       Date:  1985       Impact factor: 9.546

Review 7.  Direct vasodilators and their role in hypertension management: minoxidil.

Authors:  D A Sica; T W Gehr
Journal:  J Clin Hypertens (Greenwich)       Date:  2001 Mar-Apr       Impact factor: 3.738

8.  KY19382, a novel activator of Wnt/β-catenin signalling, promotes hair regrowth and hair follicle neogenesis.

Authors:  Yeong Chan Ryu; Dong-Hwan Lee; Jiyong Shim; Jiyeon Park; You-Rin Kim; Sehee Choi; Soon Sun Bak; Young Kwan Sung; Soung-Hoon Lee; Kang-Yell Choi
Journal:  Br J Pharmacol       Date:  2021-05-05       Impact factor: 8.739

Review 9.  Minoxidil: an underused vasodilator for resistant or severe hypertension.

Authors:  Domenic A Sica
Journal:  J Clin Hypertens (Greenwich)       Date:  2004-05       Impact factor: 3.738

10.  Resistant hypertension in nondialysis chronic kidney disease.

Authors:  Silvio Borrelli; Luca De Nicola; Giovanna Stanzione; Giuseppe Conte; Roberto Minutolo
Journal:  Int J Hypertens       Date:  2013-04-22       Impact factor: 2.420

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.